Nik Froehlich, CEO and Founder of Saritasa
In the 21st century, we are fortunate to benefit from perpetual advances in medicine. Researchers continue to discover new procedures and treatments, and those advances often rely on…
Continue Reading
In silico trials for drug safety assessment require many high-fidelity 3D cardiac simulations to predict drug-induced QT interval prolongation, which is often computationally prohibitive. To streamline this process, we developed sex-specific emulators for a…
Continue Reading
What You Should Know:
– Missouri University of Science and Technology researchers are developing new 3D-printed hydrogel dressings to speed up and improve the healing process for patients with second-degree burns. The research team published…
Continue Reading
